Follow The American Reporter's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.
You can even combine different feeds with the feed for The American Reporter.
Subscribing and unsubscribing is fast, easy and risk free.
The whole service is free of cost.
The American Reporter: The American Reporter | Breaking News at your Doorsteps
Is this your feed? Claim it!
By Yang Zhou
As the global automotive industry accelerates its transformation toward lightweight and intelligent technologies, the core demands placed on supply chains by Original Equipment Manufacturers (OEMs) are undergoing a profound evolution. The birth of a new vehicle model is not merely a convergence of design and technology, but the realization of a highly soph...
The history of women in Asia during the Second World War is often discussed through a narrow set of narratives that dominate international discourse. In particular, the “comfort women” issue has become the most visible, and politically charged, reference point in discussions of wartime gender history. While this topic is undeniably significant, it does not represent the full ...
For decades, the global skies have been ruled by a comfortable duopoly: Boeing and Airbus. If you have ever boarded a commercial flight, chances are high that you flew on a plane built by one of these two giants. However, over the past few years, Boeing has lurched from one crisis to another – ranging from severe technical glitches and safety audits to a historic factory work...
Somewhere between TikTok finance content and DTC case study roundups, a number got lodged in the heads of emerging apparel founders: 70% gross margin.
The problem with that number is where it lives.
Seventy percent is a mature brand metric, earned after years of customer trust, retail presence, and repeat purchasing behaviour.
Applying i...
Introduction
The management of patients with CLL/SLL has evolved over the last decade, with targeted therapies now forming the mainstay of treatment for patients with this disease. The introduction of Bruton’s tyrosine kinase (BTK) inhibitors to the treatment armamentarium for patients with CLL/SLL has been associated with changes in treatment approaches on the ...